Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 8Prostatic Neoplasms 5Polycystic Ovary Syndrome 5Multiple Myeloma 5Colorectal Neoplasms 5Small Cell Lung Carcinoma 4Rectal Neoplasms 3Neoplasms 3Neoplasm Metastasis 3Stomach Neoplasms 2Pancreatic Neoplasms 2Fibrosis 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma, Hepatocellular 2Breast Carcinoma In Situ 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Venous Thromboembolism 1Urinary Bladder Neoplasms 1Tuberous Sclerosis 1Triple Negative Breast Neoplasms 1Thrombosis 1Sprains and Strains 1Smoldering Multiple Myeloma 1Sepsis 1Sarcoma, Ewing 1Sarcoma, Clear Cell 1Sarcoma 1

Interventions

Microscopy, Confocal 2Indocyanine Green 2Everolimus 2varlilumab 1Ultrasonography 1Sunitinib 1Simvastatin 1Radiosurgery 1Palliative Care 1Neoadjuvant Therapy 1Narrow Band Imaging 1Interferon alpha-2 1IFL protocol 1Gastrectomy 1Folfox protocol 1Endoscopic Mucosal Resection 1Drug Delivery Systems 1Drug Combinations 1Dermoscopy 1Chemoradiotherapy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Margins of Excision × Simvastatin × Clear all
NCT04418089 2020-06-05

Simvastatin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response and Tumor-Free Margin in Locally Advanced Breast Cancer

Indonesia University

Phase 2 Completed
60 enrolled
Breast

Margins of Excision, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡